Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

RF-based therapies might help treat hair loss.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

A 54-year-old man with painful skin blisters and fever was diagnosed with Sweet syndrome and successfully treated with corticosteroids.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib is an effective and safe treatment for alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.